![Charlotta Gauffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charlotta Gauffin
Technik-/Wissenschafts-/F&E-Leiter bei
DICOT PHARMA AB
Profil
Charlotta Gauffin is currently Chief Scientific Officer at Dicot Pharma AB since 2022.
Former positions include Head-Clinical Trial Management at LIDDS AB from 2019 to 2022, and Manager-Clinical Project & Program Director at Medivir AB, Biovitrum AB, and Galderma Holding AB. Education includes graduate and doctorate degrees from the University of Uppsala.
Aktive Positionen von Charlotta Gauffin
| Unternehmen | Position | Beginn |
|---|---|---|
| DICOT PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 11.07.2022 |
Ehemalige bekannte Positionen von Charlotta Gauffin
| Unternehmen | Position | Ende |
|---|---|---|
| LIDDS AB | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
Galderma Holding AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Technik-/Wissenschafts-/F&E-Leiter | - |
| MEDIVIR AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Charlotta Gauffin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galderma Holding AB | |
Dicot Pharma AB
 Dicot Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs to treat erectile failure | Health Technology |
Wählen Sie MarketScreener 
